Related Experiment Video
Updated: Aug 8, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Is interferon-beta an alternative treatment for chronic hepatitis C?
Ricardo Moreno-Otero1, María Trapero-Marugán, Elena Gómez-Domínguez
1Unit of Hepatology, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Spain. rmoreno.hlpr@salud.madrid.org
World Journal of Gastroenterology
|May 24, 2006
Summary
Interferon-beta (IFNbeta) may offer a tolerable alternative for chronic hepatitis C (CHC) patients unresponsive to standard Interferon-alpha (IFNalpha) therapy. Further research is recommended to assess its efficacy in larger patient groups.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Standard Interferon-alpha (IFNalpha) plus ribavirin therapy for chronic hepatitis C (CHC) is suboptimal for certain patient groups.
- Alternative treatments are needed for non-responders and those experiencing adverse events with standard therapy.
Purpose of the Study:
- To evaluate the potential of Interferon-beta (IFNbeta) as an alternative treatment for CHC.
- To explore the efficacy and tolerability of IFNbeta, particularly in patients who do not respond to or tolerate IFNalpha.
Main Methods:
- Review of existing pilot studies and clinical trial data on IFNbeta in CHC treatment.
- Analysis of patient subgroups, including non-responders to IFNalpha and those with adverse events.
Main Results:
- IFNbeta has shown promising results in specific patient subgroups who are refractory to IFNalpha.
- IFNbeta demonstrates good tolerability, with low rates of dose reduction or treatment discontinuation.
Conclusions:
- IFNbeta presents a potentially valuable and well-tolerated option for CHC patients.
- Further randomized controlled trials with larger cohorts are warranted to confirm the efficacy of IFNbeta plus ribavirin in non-responders and intolerant patients.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...